Search Results

81 - 90 of 111 items :

Clear All
Protective Effects of Agmatine against Chlorpromazine- Induced Toxicity in the Liver of Wistar Rats

://dx.doi.org/10.1089/jmf.2013.0111 8. Maslak E, Zabielski P, Kochan K et al. The liverselective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet. Biochem Pharmacol 2015; 93: 389-400. http://dx.doi.org/10.1016/j.bcp.2014.12.004 9. Sharipov RR, Kotsiuruba AV, Kop"iak BS et al. Induction of nitrosative stress in mitochondria of rats hearts in experimental ischemia-reperfusion of the brain and its correction by ecdysterone. Fiziol Zh 2014; 60: 3-13. 10. Akyol

Open access
Abnormal lipid metabolism in metabolic syndrome: an epigenetic perspective

epigenome and later health consequences. Food Science and Human Wellness. 2013;2(1):1-11. DOI: 10.1016/j.fshw.2013.03.002. 4. Ginsberg HN, Stalenhoef AFH. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. J Cardiovasc Risk. 2003; 10(2):121-8. DOI: 10.1177/174182670301000207 DOI: 10.1097/00043798-200304000-00007. 5. Brudaşcă I, Cucuianu M. Pathogenic role of abnormal fatty acids and adipokines in the portal flow. Relevance for the metabolic syndrome, hepatic steatosis and steatohepatitis. Rom J Int Med. 2007

Open access
Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients?

. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. Journal of Endocrinology 2013; 218(3): R25–R36. 18. Al Rifai M, Silverman MG, Nasir K, Budoff MJ, Blankstein R, Szklo M, et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2015; 239(2): 629–33. 19. Ramadan RA. Serum vaspin and insulin resistance: predictors of steatosis and fibrosis in Egyptian

Open access
Effects of simvastatin and fenofibrate on butyrylcholinesterase activity in the brain, plasma, and liver of normolipidemic and hyperlipidemic rats

.metabol.2013.12.009 38. Kallai-Sanfacon MA, Cayen MN, Dubuc J, Greselin E, Dvornik D. Effect of AY-25,712 and other lipid-lowering agents on liver catalase and liver carnitine acetyltransferase in rats. Proc Soc Exp Biol Med 1983;173:367-71. doi: 10.3181/00379727-173-41658 39. Harano Y, Yasui K, Toyama T, Nakajima T, Mitsuyoshi H, Mimani M, Hirasawa T, Itoh Y, Okanoue T. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver Int 2006

Open access
Difference in Markers of Microbial Translocation and Cell Apoptosis in HIV Monoinfected and HIV/HCV Coinfected Patients

independently predict mortality in HIV patients. J. Infect. Dis., 203 , 780–790. Sandler, N. G., Douek, D. C. (2012). Microbial translocation in HIV infection: Causes, consequences and treatment opportunities. Nature Rev. Microbiol. , 10 , 655–666. Seidel, N., Volkmann, X., Langer, F., Flemming, P., Manns, M. P., Schulze-Osthoff, K., Bantel, H. (2005). The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology , 42 , 113–120. Vassallo, M., Mercie, P., Cottalorda, J., Ticchioni, M

Open access
Hepatitis B or C virus coinfection in and risks for transaminitis in human immunodeficiency virus - infected Thais on combined antiretroviral therapy

patients coinfected with HCV, is associated with hepatic steatosis, a common complication of HCV infection [ 27 , 28 ]. Accumulating evidence suggests that coinfection of HCV accelerates the progression of HCV-related diseases including fibrosis, cirrhosis, and end-stage liver disease in HIV patients, and that treatment with HAART does not seem to improve prognosis of the liver diseases related to HCV infection [ 2 , 29 ]. The current use of antiviral therapy against HCV infection in HCV–HIV coinfected patients seems to delay the progression to chronic liver disease

Open access
Influence of Type 2 Diabetes and the Sex on the Occurrence of Sub-Clinic Left-Ventricular Diastolic Dysfunction of the Heart

-insulin - dependent diabetes mellitus. Am J Cardiol. 1992;70:371. 69. Fiorini G, Scotti LA, Parmigiani ML, Ferrari M, Pezzoli P, Bignotti G. [An echocardiographic study of left ventricular diastolic function in patients with diabetes mellitus type 2]. G Ital Cardiol. 1995;25(1):17-25. 70. Luuk JR, Rudger VM, Johannes WS et al. Myocardial steatosis is an independent predictor of diastolic disfungcijon in type-2 diabetes mellitus. J Am Coll Cardiol. 2008.52;(22):1793-99. 71. Vinereanu D, Nicolaides E, Tweddel AC, et al. Subclinicl levt

Open access
The Role of Autophagy in Immunity and Autoimmune Diseases / Uloga Autofagije U Imunskom Odgovoru I Autoimunskim Bolestima

. 1124-32. 74. Zhao, Z., et al., Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe, 2008. 4(5): p. 458-69. 75. Jung, H.S., et al., Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab, 2008. 8(4): p. 318-24. 76. Okada, K., et al., The alpha-glucosidase inhibitor acarbose prevents obesity and simple steatosis in sequestosome 1/A170/p62 deficient mice. Hepatol Res, 2009. 39

Open access
Effects of exposure to three environmental chemicals on the selected biochemical parameters of the blood plasma of rainbow trout, Oncorhynchus mykiss (Walbaum)

References Austin B. & Austin D.A. (2012): Bacterial fish Pathogens: Disease of Farmed and Wild Fish. Fifth Edition. Springer Dordrecht Heidelberg New York London, 652 pp. Balint T., Szegletes T., Szegletes Z., Halasy K. & Nemcsok J. (1995): Biochemical and subcellular changes in carp exposed to the organophosphorous methidation and the pyrethroid deltamethrin. - Aquatic Toxicology 33: 279-295. Braunbeck T., Görge G., Stor ch V. & Nagel R. (1990): Hepatic steatosis in zebrafish (Brachydanio rerio) induced by

Open access
Effects of Silybum marianum Extract on High-Fat Diet Induced Metabolic Disorders in Rats

fibrosis in patients with hepatic steatosis Preliminary study. Minerva Gastroenterol Dieto., 2005, 51, 193–199 (in Italian). 55. Tsai J.H., Liu J.Y., Wu T.T., Ho P.C., Huang C.Y., Shyu J.C., Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. J. Viral Hepat., 2008, 15, 508–514. 56. Vengerovskii A.I., Khazanov V.A., Eskina K.A., Vasilyev K.Y., Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus. Bull. Exp. Biol. Med., 2007, 144, 53

Open access